Add BrightSurf on Google Email

Insilico Medicine nominates ISM6200, a potential best-in-class selective NR3C1 inhibitor for ovarian cancer, Cushing’s Syndrome, hypercortisolism-associated obesity and glaucoma

ISM6200 is a potent, potentially best-in-class preclinical candidate targeting NR3C1 for the treatment of ovarian cancer, Hypercortisolism (Cushing’s Syndrome), and other disorders related to excess cortisol. The molecule demonstrates low DDI risks and higher in vivo efficacy across multiple animal models.

Artificial intelligence could transform patient education in eye care, new research shows

A new AI chatbot helps patients access retinal detachment advice through personalized, real-time, clinically grounded conversations. The system outperformed leading large language models and includes accessibility features for people with low vision or limited English proficiency.

SourceUniversity of East London·JournalJournal of Artificial Intelligence and Robotics·TypeComputational simulation/modeling·DateApr 1, 2026

Can a specialized AI model steer doctors toward the right scan?

A specialized AI model, AMIR-GPT, has been developed to improve radiology guideline alignment, outperforming general purpose models in 33.3% of test responses. However, the model's performance varied across performance bands, and qualitative review revealed limitations, such as omissions and deviations from standard recommendations.

SourceIntelligent Medicine·JournalIntelligent Medicine·TypeComputational simulation/modeling·DateMar 17, 2026

How AI-generated images are detected: advances, benchmarks and open challenges

The study provides a systematic overview of AI-generated image detection, categorizing existing methods across multiple dimensions and evaluating their performance in a unified framework. Key challenges include constructing large-scale unbiased datasets, improving robustness, and increasing interpretability of detection outcomes.

SourceBeijing Zhongke Journal Publising Co. Ltd.·JournalJournal of Image and Graphics·DateMar 12, 2026

Insilico and TaiGen achieve milestone in collaboration: Out-licensed CKD anemia candidate ISM4808 completes first human enrollment and dosing in Phase I clinical trial

ISM4808, a PHD inhibitor for chronic kidney disease-related anemia, has achieved its first milestone with successful completion of the Phase I clinical trial. The treatment stimulates endogenous erythropoietin production and improves iron utilization, offering improved efficiency and safety compared to existing treatments.

Children’s Hospital of Philadelphia researchers emphasize benefits and risks of generative AI at different stages of childhood development

Children's Hospital of Philadelphia researchers highlight the need for parents and pediatricians to understand generative AI's potential benefits and risks for children of different ages. Early childhood (0-5 years) requires close supervision, while middle childhood (6-11 years) and adolescence (12+ years) require critical thinking ski...

SourceChildren's Hospital of Philadelphia·JournalPEDIATRICS·TypeSystematic review·DateMar 4, 2026

Machines spot deepfake pictures better than humans, but people outperform AI in detecting deepfake videos

A recent study found that AI programs are up to 97% accurate at detecting pictures of deepfake faces, but performed at chance levels when it comes to detecting deepfake videos. Humans correctly identified real and fake videos about two-thirds of the time, picking up on subtle inconsistencies in movement and facial expressions. The stud...

SourceUniversity of Florida·JournalCognitive Research Principles and Implications·TypeExperimental study·DateMar 4, 2026

Don’t Panic: ‘Humanity’s Last Exam’ has begun

A global consortium created an exam with 2,500 questions spanning multiple subjects to assess AI capabilities. Current AI models consistently fail the exam, highlighting gaps in their understanding. The project aims to provide a long-term benchmark for evaluating advanced AI systems and demonstrate the importance of human expertise

SourceTexas A&M University·JournalNature·DateFeb 25, 2026

Reminding people they’re talking to chatbots may be ineffective or even harmful, researchers say

Researchers argue that mandated reminders about a chatbot's non-human nature may exacerbate mental distress and form stronger attachments. The warnings come after recent deaths by suicide linked to chatbots like ChatGPT and Character.AI, highlighting the need for careful crafting and timing of these reminders.

SourceCell Press·JournalTrends in Cognitive Sciences·TypeCommentary/editorial·DateFeb 18, 2026

AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases

Insilico Medicine and CMS announce multiple collaborations on AI-empowered drug discovery in central nervous system and autoimmune diseases. The partnerships aim to accelerate research, development, and translation of high-potential innovative therapies, leveraging complementary strengths across the entire value chain.

How mindfulness can support GenAI use in transforming project management

A recent study revealed the critical connection between mindfulness and the adoption of generative artificial intelligence (GenAI) in project management. Project managers with higher mindfulness levels tend to be more open, attentive, and creative in crafting their immediate work environment, encouraging them to explore how GenAI can o...

SourceEdith Cowan University·JournalInternational Journal of Project Management·TypeSurvey·DateFeb 3, 2026

Generative AI applications use among us youth

A cross-sectional study found that up to half of adolescents in the US were using generative AI apps, while a small subset engaged in heavy use. The study highlights the need for future research on individual differences in GenAI use and its impacts on adolescent development.

SourceJAMA Network·JournalJAMA Network Open·DateFeb 2, 2026

HSE scientists uncover how authoritativeness shapes trust

Researchers at HSE Institute for Cognitive Neuroscience found that people tend to trust the current opinion of an authoritative speaker even when new statements contradict their previous position. The study used AI-generated audio recordings of celebrities with opposing views on COVID-19 vaccination and found that participants rated th...

SourceNational Research University Higher School of Economics·JournalNeuroImage·TypeExperimental study·DateJan 29, 2026

Up to 31.3% body weight loss, Insilico Medicine nominates AI-powered GIPR antagonist ISM0676 as preclinical candidate, showing synergistic efficacy in combination therapy

ISM0676 demonstrates excellent metabolic stability, superior efficacy at low doses, and a favorable safety profile, leading to significant body weight reduction and improved body composition. The compound's synergistic efficacy with Semaglutide supports its further clinical development as an obesity treatment.